374 related articles for article (PubMed ID: 32085664)
1. Autoantibody Biomarkers in Rheumatic Diseases.
Kang EH; Ha YJ; Lee YJ
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085664
[TBL] [Abstract][Full Text] [Related]
2. A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders.
Stinton LM; Fritzler MJ
Autoimmun Rev; 2007 Nov; 7(1):77-84. PubMed ID: 17967730
[TBL] [Abstract][Full Text] [Related]
3. Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective.
Gross WL; Schmitt WH; Csernok E
Am J Kidney Dis; 1991 Aug; 18(2):175-9. PubMed ID: 1867175
[TBL] [Abstract][Full Text] [Related]
4. [Significance of autoantibodies in rheumatic diseases].
Teng Q
Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):315-7. PubMed ID: 15157401
[No Abstract] [Full Text] [Related]
5. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases.
Nakamura RM; Tan EM
Clin Lab Med; 1992 Mar; 12(1):1-23. PubMed ID: 1563236
[TBL] [Abstract][Full Text] [Related]
6. [Antineutrophilic cytoplasmic antibodies (ANCA) in inflammatory rheumatic diseases: immunodiagnostic and immunopathogenetic aspects].
Csernok E; Gross WL
Z Rheumatol; 1995; 54(1):26-38. PubMed ID: 7725808
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of autoantibodies in systemic rheumatic diseases.
Fritzler MJ
Mol Biol Rep; 1996; 23(3-4):133-45. PubMed ID: 9112221
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies and rheumatology.
Williams RC
Br J Rheumatol; 1994 Dec; 33(12):1097-8. PubMed ID: 8000732
[No Abstract] [Full Text] [Related]
9. The MRZ-Reaction and Specific Autoantibody Detection for Differentiation of ANA-Positive Multiple Sclerosis From Rheumatic Diseases With Cerebral Involvement.
Venhoff N; Thiel J; Rizzi M; Venhoff A; Rauer S; Endres D; Hentze C; Staniek J; Huzly D; Voll RE; Salzer U; Hottenrott T
Front Immunol; 2019; 10():514. PubMed ID: 30941143
[No Abstract] [Full Text] [Related]
10. Use and interpretation of rheumatologic tests: a guide for clinicians.
Moder KG
Mayo Clin Proc; 1996 Apr; 71(4):391-6. PubMed ID: 8637264
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in ANCA-associated vasculitis.
Wiik AS
Rheum Dis Clin North Am; 2010 Aug; 36(3):479-89. PubMed ID: 20688245
[TBL] [Abstract][Full Text] [Related]
12. Role of autoantibody testing.
Aggarwal A
Best Pract Res Clin Rheumatol; 2014 Dec; 28(6):907-20. PubMed ID: 26096093
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies directed against lysozyme: a new target antigen for anti-neutrophil cytoplasmic antibodies (ANCA).
Schmitt WH; Csernok E; Flesch BK; Hauschild S; Gross WL
Adv Exp Med Biol; 1993; 336():267-72. PubMed ID: 8296617
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in vasculitis.
Hatemi G; Esatoglu SN; Yazici Y
Curr Opin Rheumatol; 2018 Jan; 30(1):30-35. PubMed ID: 28937415
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases.
Uesugi H; Ozaki S; Sobajima J; Osakada F; Shirakawa H; Yoshida M; Nakao K
J Rheumatol; 1998 Apr; 25(4):703-9. PubMed ID: 9558172
[TBL] [Abstract][Full Text] [Related]
16. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies.
Jennette JC; Falk RJ
Curr Opin Rheumatol; 2008 Jan; 20(1):55-60. PubMed ID: 18281858
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?
Mohan C; Assassi S
BMJ; 2015 Nov; 351():h5079. PubMed ID: 26612523
[TBL] [Abstract][Full Text] [Related]
18. Emerging technologies in autoantibody testing for rheumatic diseases.
Olsen NJ; Choi MY; Fritzler MJ
Arthritis Res Ther; 2017 Jul; 19(1):172. PubMed ID: 28738887
[TBL] [Abstract][Full Text] [Related]
19. [Autoantibodies, diagnostic and prognostic markers of rheumatoid polyarthritis].
Sibilia J
Presse Med; 2000 Oct; 29(31):1723-30. PubMed ID: 11094620
[TBL] [Abstract][Full Text] [Related]
20. IgG autoantibody to the collagen-like region of Clq in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases.
Wisnieski JJ; Jones SM
J Rheumatol; 1992 Jun; 19(6):884-8. PubMed ID: 1404125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
